GlassScriptPhysician profile
Adam Daniel Depue
NPI 1578825113
$457.07
in general payments reported to CMS, 2019-2025
12 companies · $39.09 in 2025
The $39.09 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $114 · 2023: $76.50 · 2024: $25.94 · 2025: $39.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $139.75 | 2021-2025 | Vercise, General - Pain Management |
| Abbott Laboratories | $96.88 | 2021-2022 | |
| Medtronic, INC. | $45.01 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $43.07 | 2021-2022 | |
| Innovasis INC | $24.55 | 2021 | |
| Biocomposites INC | $20.39 | 2021 | |
| Integra Lifesciences Corporation | $18.71 | 2025 | Codman Certas, Cusa Clarity, Codman Hakim |
| Surgalign Spine Technologies, INC. | $15.15 | 2021 | |
| Stryker Corporation | $14.39 | 2021 | |
| Relievant Medsystems, INC. | $13.93 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.50 | 2021 | |
| Orthofix Medical, INC. | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Depue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.